-
NMPA Approves Shenzhen Mindray’s Innovative Dual-Mode Ultrasound Diagnostic System
•
The National Medical Products Administration (NMPA) has granted approval to Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) for its innovative ultrasound diagnostic system, as announced on the bureau’s website. Introducing the First Dual-Mode Imaging Product in ChinaThe approved product is hailed as China’s first dual-mode imaging product, integrating both…
-
Mindray Bio-Medical Partners with Nanjing Drum Tower Hospital to Boost Clinical Research
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical equipment provider, has entered into a partnership with Nanjing Drum Tower Hospital, a prestigious and historically significant hospital in China. The collaboration will focus on key medical disciplines of the hospital and involve clinical study cooperation as part of…
-
Caprico Biotechnologies and Mindray Medical Form Comprehensive Flow Testing Partnership
•
Caprico Biotechnologies, Inc., a Chinese biotechnology company, has entered into a comprehensive partnership with Mindray Medical International Limited, a fellow Chinese firm, to collaborate on research and development, manufacturing, and marketing in the field of flow testing. The agreement encompasses a wide range of activities, although financial specifics have not…
-
Mindray Bio-Medical Electronics Reports 11.12% YOY Revenue Growth in 2024H1
•
SHENZHEN—Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has announced its financial results for the first half of 2024, with revenues reaching RMB 20.53 billion, marking an 11.12% year-on-year increase. The net profit saw a robust rise, climbing to RMB 7.56 billion, which is a 17.37% increase. Despite a 7.59% YOY…
-
Mindray Medical Forges Comprehensive Partnership with CUHK-Shenzhen School of Medicine
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a prominent medical device company based in China, has entered into a strategic partnership with the CUHK-Shenzhen School of Medicine. The collaboration aims to foster comprehensive and in-depth cooperation across various domains, including industrial-university research, international academic exchanges, and talent development. The…
-
Mindray Bio-Medical Partners with Nanjing Municipal Government to Boost Healthcare Innovation
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading player in the global medical device market, has entered into a strategic partnership with the municipal government of Nanjing. This collaboration aims to drive an extensive, multi-tiered, and broad application of scientific research achievements within the healthcare sector, enhancing both…
-
Mindray Bio-Medical Electronics Reports 15.04% YOY Revenue Growth in 2023 Financial Results
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has announced its financial results for 2023, with revenues reaching RMB 34.932 billion (USD 4.82 billion), reflecting a robust year-on-year (YOY) growth of 15.04%. Net profits for the medical equipment manufacturer surged to RMB 11.58 billion (USD 1.6 billion), marking an increase…
-
Mindray to Acquire 21.12% Stake in APT Medical for RMB 6.652 Billion
•
Mindray (SHE: 300760), a leading China-based medtech firm, has announced plans to acquire a 21.12% stake in APT Medical Inc., a Shenzhen-based specialist in cardiac electrophysiology that went public on Shanghai’s STAR market in 2021. The acquisition will cost Mindray approximately RMB 6.652 billion (USD 926.6 million). Additionally, Mindray will…
-
Mindray Bio-Medical Electronics Posts Strong Q1-Q3 2023 Financial Results
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has revealed a robust financial performance for the Q1-Q3 2023 period. The company generated RMB 27.3 billion (USD 3.74 billion) in revenues during the first three quarters, marking a 17.2% year-on-year (YOY) increase. This growth underscores Mindray’s strong market position and effective…
-
Mindray Launches TE Air Wireless Handheld Ultrasound Solution in the US Market
•
China-based global device giant Mindray (SHE: 300760) has announced the market launch of its TE Air Wireless Handheld Ultrasound imaging solution in the United States. This innovative device offers healthcare providers (HCPs) a pocket-held scanning tool designed for use across a broad spectrum of clinical scenarios, enhancing diagnostic capabilities at…
-
Mindray Bio-Medical Electronics to Acquire Majority Stake in DiaSys Diagnostic Systems
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical device company based in China, is poised to acquire a 75% controlling stake in Germany-headquartered in vitro diagnostics (IVD) specialist DiaSys Diagnostic Systems GmbH. The transaction is valued at EUR 115 million (USD 127 million), marking a significant move…
-
Shanghai Pharmaceuticals and Mindray Form Strategic Alliance for Medical Equipment and IVD Products
•
Shanghai Pharmaceuticals (SHA: 601607, HKG: 2607), a leading pharmaceutical company in China, has announced a long-term partnership with fellow Chinese medical device firm Mindray (SHE: 300760). The collaboration will focus on medical equipment, medical consumables, and in vitro diagnostic (IVD) products. The two companies plan to integrate their existing resources…
-
Mindray Partners with Vazyme Biotech to Develop Automated Infection Screening Solutions
•
China-based medical device company Mindray (SHE: 300760) has entered into a partnership with fellow Chinese firm Vazyme Biotech Co., Ltd. (SHA: 688105). The collaboration aims to develop a comprehensive automated solution for infection screening and respiratory pathogen detection. Advancing Diagnostic Capabilities with AutomationThe partnership will leverage the combined expertise of…
-
Mindray Reports Strong YOY Growth in 2022 and Q1 2023 Financial Results
•
China-based medical device firm Mindray (SHE: 300760) has released its financial reports for the year 2022 and the first quarter of 2023, showcasing robust growth across its main business units. In 2022, the company recorded a revenue of RMB 30.366 billion (USD 4.4 billion), marking a 20.17% increase year-on-year (YOY),…
-
Mindray Launches First Wireless Handheld Ultrasound System, TE Air
•
China-based medical device firm Mindray (SHE: 300760) has announced the market launch of the firm’s first wireless handheld ultrasound system, branded TE Air. This innovative device represents a historic breakthrough in image quality, integrating professional-level imaging into a compact and lightweight wireless system for ease of use in various medical…
-
Mindray Partners with BOMImed for Exclusive Canadian Sales and Service
•
China-based medical device giant Mindray’s North American unit has announced a partnership with Canadian biomedical firm BOMImed Inc. The deal appoints BOMImed as the exclusive sales and service provider for Mindray’s patient monitoring, anesthesia, and ultrasound solutions in Canada’s hospital market. This strategic move aims to enhance Mindray’s presence in…
-
National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products
•
The national high-value medical consumables joint procurement office released a set of guiding opinions on the national high-value medical consumables volume-based procurement (VBP), publishing the filing invitation and procurement volume for orthopedic spine medical consumable products. The VBP round will include anterior cervical screw plates, posterior cervical screw rods, posterior…
-
Mindray Bio-Medical’s H1 2022 Revenues Jump 20.17% to RMB 15.3B
•
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) reported robust financial results for H1 2022, with revenues reaching RMB 15.3 billion (USD 2.24 billion), up 20.17% year-on-year (YOY). Net profits rose 21.71% YOY to RMB 5.28 billion (USD 773 million). Business Segments R&D InvestmentMindray invested RMB 1.45 billion (USD 212…
